Critical factor | Corresponding NHS Long Term Plan objectives | |||||
3.67 | 3.68 | 3.69 | 3.70 | 3.71 | 3.72 | |
1 Access to integrated care records for CVD | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
2 Effective processes for inviting for CVD review in primary care | ✓ | ✓ | ✓ | |||
3 Effectiveness of CVD reviews in primary care | ✓ | ✓ | ✓ | |||
4 Effective treatment of identified patients with CVD | ✓ | ✓ | ||||
5 Patients with AF are appropriately managed on anticoagulant | ✓ | |||||
6 Processes in place to enable prescription of DOAC at diagnosis for patients with AF | ✓ | |||||
7 Identification of people with familial hypercholesterolaemia | ✓ | |||||
8 At-risk patients with CHd are appropriately treated with aspirin or alternative agent | ✓ | |||||
9 Access to local practice pharmacists for CHD management | ✓ | |||||
10 Access to appropriate HF diagnostics | ✓ | |||||
11 Access to local specialist HF nurses | ✓ | |||||
12 Appropriate provision of cardiac rehabilitation services | ✓ | |||||
13 Appropriate access to cardiac rehabilitation services | ✓ | |||||
14 Cardiac rehabilitation is resourced appropriately | ✓ | |||||
15 Processes for actively managing CVD review invitations | ✓ | ✓ | ✓ | |||
16 Delivering CVD review management | ✓ | ✓ | ✓ | |||
17 Identifying CVD review patients | ✓ | ✓ | ✓ | ✓ | ||
18 Ability to identify patients with AF | ✓ | |||||
19 Availability of familial hypercholesterolaemia service | ✓ | |||||
20 There is confidence in awareness and diagnosis of HF | ✓ | |||||
21 There are sufficient community defibrillators for ICS demographics | ✓ |
AF, atrial fibrillation; CHD, coronary heart disease; CVD, cardiovascular disease; DOAC, direct-acting oral anticoagulant; HF, heart failure.